Molecular Biology of the Cell click for ASCB 2009 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Originally published as MBC in Press, 10.1091/mbc.E03-08-0578 on November 14, 2003

Vol. 15, Issue 1, 323-331, January 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow All Versions of this Article:
E03-08-0578v1
15/1/323    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsen, J. E.
Right arrow Articles by Kirchhausen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsen, J. E.
Right arrow Articles by Kirchhausen, T.

HIV Nef-mediated Major Histocompatibility Complex Class I Down-Modulation Is Independent of Arf6 Activity

Jakob E. Larsen *, Ramiro H. Massol *, Thomas J. F. Nieland, and Tomas Kirchhausen {dagger}

Department of Cell Biology and The Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115

Submitted August 11, 2003; Revised September 3, 2003; Accepted September 10, 2003
Monitoring Editor: Juan Bonifacino

HIV Nef has a number of important biological effects, including the down-modulation of several immunological important molecules (CD4, major histocompatibility complex [MHC] class I). Down-modulation of CD4 seems to be via clathrin-dependent endocytosis, whereas down-modulation of MHC class I remains unexplained. Several mutant proteins, including mutations in the small GTPase Arf6, have been used to probe membrane traffic pathways. One such mutant has recently been used to propose that Nef acts through Arf6 to activate the endocytosis of MHC class I. Here, we show that MHC class I down-modulation is unaffected by other Arf6 mutants that provide more specific perturbations in the GDP-GTP cycling of Arf6. Inhibition of phosphatidylinositol-3-phosphate kinase, an upstream activator of Arf6, also had no effect on the internalization step, but its activity is required to direct MHC class I to the trans-Golgi network. We conclude that the apparent Arf6 dependency of Nef-mediated MHC class I down-modulation is due to nonspecific perturbations in membrane traffic.

Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E03–08–0578. Article and publication date are available at www.molbiolcell.org/cgi/doi/10.1091/mbc.E03–08–0578.

* These authors contributed equally to this work.

{dagger} Corresponding author. E-mail address: kirchhausen{at}crystal.harvard.edu.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
K. M. Atkins, L. Thomas, R. T. Youker, M. J. Harriff, F. Pissani, H. You, and G. Thomas
HIV-1 Nef Binds PACS-2 to Assemble a Multikinase Cascade That Triggers Major Histocompatibility Complex Class I (MHC-I) Down-regulation: ANALYSIS USING SHORT INTERFERING RNA AND KNOCK-OUT MICE
J. Biol. Chem., April 25, 2008; 283(17): 11772 - 11784.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
N. Casartelli, G. Giolo, F. Neri, C. Haller, M. Potesta, P. Rossi, O. T. Fackler, and M. Doria
The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner.
J. Gen. Virol., August 1, 2006; 87(Pt 8): 2291 - 2296.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
J. F. Roeth and K. L. Collins
Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways
Microbiol. Mol. Biol. Rev., June 1, 2006; 70(2): 548 - 563.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
N. Naslavsky and S. Caplan
C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?
J. Cell Sci., September 15, 2005; 118(18): 4093 - 4101.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Williams, J. F. Roeth, M. R. Kasper, T. M. Filzen, and K. L. Collins
Human Immunodeficiency Virus Type 1 Nef Domains Required for Disruption of Major Histocompatibility Complex Class I Trafficking Are Also Necessary for Coprecipitation of Nef with HLA-A2
J. Virol., January 1, 2005; 79(1): 632 - 636.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. F. Roeth, M. Williams, M. R. Kasper, T. M. Filzen, and K. L. Collins
HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail
J. Cell Biol., December 6, 2004; 167(5): 903 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
E. Cocucci, G. Racchetti, P. Podini, M. Rupnik, and J. Meldolesi
Enlargeosome, an Exocytic Vesicle Resistant to Nonionic Detergents, Undergoes Endocytosis via a Nonacidic Route
Mol. Biol. Cell, December 1, 2004; 15(12): 5356 - 5368.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
L. Lu, G. Tai, and W. Hong
Autoantigen Golgin-97, an Effector of Arl1 GTPase, Participates in Traffic from the Endosome to the Trans-Golgi Network
Mol. Biol. Cell, October 1, 2004; 15(10): 4426 - 4443.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
R. H. Massol, J. E. Larsen, Y. Fujinaga, W. I. Lencer, and T. Kirchhausen
Cholera Toxin Toxicity Does Not Require Functional Arf6- and Dynamin-dependent Endocytic Pathways
Mol. Biol. Cell, August 1, 2004; 15(8): 3631 - 3641.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.